tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DWTX Stock Latest News

Dogwood announces interim Phase 2b trial results on Halneuron
The FlyDogwood announces interim Phase 2b trial results on Halneuron
2d ago
DWTX
Dogwood files for IP protection for synthetic Halneuron
PremiumThe Fly
Dogwood files for IP protection for synthetic Halneuron
22d ago
DWTX
Dogwood Therapeutics Approves Equity Plan Amid Business Merger
PremiumCompany Announcements
Dogwood Therapeutics Approves Equity Plan Amid Business Merger
1M ago
8K
DWTX
Dogwood enrolls first 100 patients in Halneuron Phase 2b trial
PremiumThe Fly
Dogwood enrolls first 100 patients in Halneuron Phase 2b trial
1M ago
DWTX
Strategic Acquisitions and Promising Trials Bolster Buy Rating for Dogwood Therapeutics
PremiumRatings
Strategic Acquisitions and Promising Trials Bolster Buy Rating for Dogwood Therapeutics
1M ago
DWTX
Dogwood Therapeutics Advances Pain Treatment Pipeline
PremiumCompany AnnouncementsDogwood Therapeutics Advances Pain Treatment Pipeline
2M ago
DWTX
Dogwood reports Q3 EPS ($8.20) vs ($2.05) last year
Premium
The Fly
Dogwood reports Q3 EPS ($8.20) vs ($2.05) last year
2M ago
DWTX
Dogwood Therapeutics Announces Business Combination Plans
Premium
Company Announcements
Dogwood Therapeutics Announces Business Combination Plans
3M ago
8K
DWTX
Dogwood to present on Halneuron pain research program
PremiumThe Fly
Dogwood to present on Halneuron pain research program
3M ago
DWTX
Dogwood files to sell 28.04M shares of common stock for holders
PremiumThe Fly
Dogwood files to sell 28.04M shares of common stock for holders
3M ago
DWTX
Strategic Advancements and Growth Potential: Dogwood Therapeutics’ Acquisition of SP16
PremiumRatings
Strategic Advancements and Growth Potential: Dogwood Therapeutics’ Acquisition of SP16
3M ago
DWTX
Dogwood price target raised to $12 from $10 at H.C. Wainwright
PremiumThe Fly
Dogwood price target raised to $12 from $10 at H.C. Wainwright
3M ago
DWTX
Dogwood Therapeutics Secures Licensing Deal with Serpin Pharma
PremiumCompany AnnouncementsDogwood Therapeutics Secures Licensing Deal with Serpin Pharma
3M ago
8K
DWTX
Dogwood secures royalty free license to develop, commercialize SP16
Premium
The Fly
Dogwood secures royalty free license to develop, commercialize SP16
3M ago
DWTX
Buy Rating for Dogwood Therapeutics: Promising Phase 2b Study Results and Strategic Financial Positioning
Premium
Ratings
Buy Rating for Dogwood Therapeutics: Promising Phase 2b Study Results and Strategic Financial Positioning
4M ago
DWTX
Dogwood Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Dogwood Therapeutics Reports Q2 2025 Financial Results
4M ago
DWTX
Dogwood reports Q2 EPS ($1.99) vs ($1.15) last year
PremiumThe Fly
Dogwood reports Q2 EPS ($1.99) vs ($1.15) last year
4M ago
DWTX
Dogwood Therapeutics Approves CFO Salary Increase
PremiumCompany Announcements
Dogwood Therapeutics Approves CFO Salary Increase
6M ago
8K
DWTX
Dogwood Therapeutics Approves Equity Plan Amendment
PremiumCompany Announcements
Dogwood Therapeutics Approves Equity Plan Amendment
6M ago
8K
DWTX
Dogwood files $150M mixed securities shelf
PremiumThe FlyDogwood files $150M mixed securities shelf
7M ago
DWTX
Promising Growth Potential for Dogwood Therapeutics with Halneuron’s Development and Strong Financial Position
Premium
Ratings
Promising Growth Potential for Dogwood Therapeutics with Halneuron’s Development and Strong Financial Position
8M ago
DWTX
Buy Rating for Dogwood Therapeutics Driven by Promising Clinical Developments and Strong Financial Outlook
Premium
Ratings
Buy Rating for Dogwood Therapeutics Driven by Promising Clinical Developments and Strong Financial Outlook
8M ago
DWTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >